Read more about our previous research and practice efforts below.
The overall goal of this project is to estimate measures of validity in self-reported vaccine status for nine vaccines (influenza; pneumococcal; herpes zoster; tetanus-diphtheria [Td]; tetanus-diphtheria-pertussis [Tdap]; human papillomavirus [HPV]; hepatitis A; hepatitis B; and COVID-19) within demographic and disease risk groups. These measures include sensitivity, specificity, and net bias. These measures will then be used to adjust estimates produced by self-report surveys, resulting in better information on which to base programmatic decisions and efforts to increase the uptake of vaccines throughout the U.S. These estimates of validity must be vaccine-specific and specific to demographic and risk factor groups, because some groups may be able to more accurately report their vaccine status than others. We will also conduct an in-depth examination of alternative non-survey sources for estimating vaccine coverage and produce a White Paper on this issue.
This study conducted a randomized controlled trial to test the effects of online training with a diverse group of providers from Colorado and Virginia on the management of prenatal depression.
The online training provided an overview of the harmful effects of prenatal depression on numerous maternal and child outcomes, as well as provided a framework that used the 5As model (i.e. Assess, Advise, Agree, Assist and Arrange) to teach providers how to 1) assess for depression, 2) advise the patient on treatment options, 3) agree on a treatment plan, 4) assist the patient in any problem solving related to obtaining treatment, and 5) arrange for supports for the patient (e.g. link patients to mental health resources in the community).